TIGER COMBINATION PRODUCT OINTMENT

Indications

• Respiratory tract infections
• Bronchitis
• Muscle pain
• Joint pain
• Skin irritations
• Headaches

Dosage

Children: Caution is advised when using cajuput oil in children. Generally, topical application should be performed with appropriate dilution in a carrier oil.

Adults: Topical application is common, typically diluted in a carrier oil. For respiratory issues, inhalation of steam with cajuput oil may be recommended. Refer to specific guidelines or clinical advice for detailed dosing.

Mechanism of action

Cajuput oil primarily exerts its effects through its active constituents, such as 1,8-cineole (eucalyptol), which acts as a mucolytic agent and helps to loosen mucus in the airways. Additionally, its antimicrobial properties are attributed to its ability to disrupt microbial cell membranes, leading to cell lysis. The oil may also exert anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines.

Pharmacodynamics

Cajuput oil displays a range of pharmacological effects, including analgesic, anti-inflammatory, and antispasmodic activities. Its compounds can stimulate the central nervous system and improve respiratory function, making it useful in treating conditions like bronchitis and sinusitis. The oil's local irritant properties can enhance blood flow to the applied area, contributing to pain relief.

Pharmacokinetics

The pharmacokinetics of cajuput oil are not extensively studied, but it is known that when applied topically, its components can penetrate the skin and enter systemic circulation. The absorption, distribution, metabolism, and excretion of its constituents, particularly 1,8-cineole, are influenced by factors such as formulation, route of administration, and individual patient characteristics. Inhalation of the vaporized oil can lead to rapid absorption through the respiratory tract.

Adverse effects

• Allergic reactions
• Skin irritation
• Gastrointestinal upset

Precautions

• Use cautiously in individuals with known allergies to plants in the Myrtaceae family.
• Avoid contact with eyes and mucous membranes.

Pregnancy

Caution is advised as safety during pregnancy has not been established.

Breast-feeding

Limited data available; consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Topical ointments
• Inhalation solutions

Indications

• Topical pain relief
• Muscle aches
• Joint pain
• Inflammation

Dosage

Children: For children, the

Adults: For topical application, camphor is usually applied as needed to the affected area, following the instructions on the specific product used. Consult the product label or a healthcare professional for detailed dosing guidelines.

Mechanism of action

Camphor activates the transient receptor potential vanilloid 1 (TRPV1) and TRPV3 channels, which are involved in sensing pain and temperature. It requires higher concentrations to activate TRPV1 compared to capsaicin but notably desensitizes TRPV1 more rapidly and completely. This action is enhanced under inflamed conditions through phospholipase C-coupled receptor stimulation. The distinct activation pathways of camphor contribute to its analgesic effects, making it effective in reducing pain sensitivity.

Pharmacodynamics

The pharmacodynamic properties of camphor are primarily related to its interaction with TRPV1 and TRPV3 channels. By activating these receptors, camphor induces a sensation of warmth and can result in analgesia through sensory nerve excitation and subsequent desensitization. This mechanism is similar to that of other topical analgesics like capsaicin and menthol but is characterized by a faster desensitization of TRPV1. Additionally, camphor's effects may include local vasodilation and increased blood flow to the area of application, which can further alleviate pain and inflammation.

Pharmacokinetics

Camphor is absorbed through the skin when applied topically. Its pharmacokinetic profile involves distribution to various tissues, where it can exert local effects. The metabolism of camphor occurs primarily in the liver, and it is eliminated from the body mainly through urine. The onset of action is typically rapid due to its topical application, and the duration of effect may vary depending on the formulation and concentration used.

Adverse effects

• Skin irritation
• Allergic reactions
• Nausea
• Vomiting
• Dizziness

Precautions

• Use with caution in individuals with sensitive skin
• Avoid contact with eyes and mucous membranes
• Do not apply to broken or irritated skin
• Keep out of reach of children

Pregnancy

Camphor should be used with caution during pregnancy. It is advisable to consult a healthcare professional before use.

Breast-feeding

Camphor should be used with caution while breastfeeding. Consult a healthcare professional for advice.

Storage

Store in a cool, dry place, away from direct sunlight and heat.

Formulations

• Topical ointments
• Liniments
• Creams
• Gels

Indications

• Pain relief
• Anti-inflammatory conditions
• Antimicrobial applications
• Dental pain
• Digestive disorders

Dosage

Children: Refer to healthcare professional for appropriate dosing guidelines as clove oil is generally not recommended for children without medical supervision.

Adults: For topical application, clove oil can be diluted with a carrier oil and applied as needed. For oral use, standard culinary doses are generally considered safe, but specific therapeutic doses should be guided by a healthcare professional.

Mechanism of action

Eugenol, the primary active compound in clove, exhibits its effects through several pathways. It acts as an analgesic by inhibiting the synthesis of prostaglandins, which are mediators of pain and inflammation. Additionally, eugenol has been shown to interact with voltage-gated sodium channels, which may contribute to its analgesic effects. Its antimicrobial properties are partly due to its ability to disrupt the cell membranes of bacteria and fungi.

Pharmacodynamics

Clove has a variety of pharmacodynamic effects, primarily attributed to eugenol. It exhibits analgesic, anti-inflammatory, and antioxidant properties. Clove oil has been found to reduce pain and inflammation in various experimental models. Its antimicrobial activity is effective against a range of pathogens, making it a candidate for use in oral health products. Furthermore, the antioxidant properties help in neutralizing free radicals, thereby providing protective effects against cellular damage.

Pharmacokinetics

Clove oil is absorbed through the gastrointestinal tract when ingested and can also be absorbed through the skin when applied topically. The bioavailability of eugenol can be influenced by its formulation and method of administration. Once absorbed, eugenol is distributed throughout the body, metabolized primarily in the liver, and excreted via the kidneys. The half-life of eugenol varies but is generally short, necessitating frequent dosing for sustained effects in therapeutic use.

Adverse effects

• Allergic reactions
• Gastrointestinal irritation
• Liver toxicity with excessive use
• Hypoglycemia

Interactions

• May enhance the effects of anticoagulants
• May interact with antidiabetic medications
• May reduce the effectiveness of certain antiepileptic drugs

Precautions

• Use with caution in individuals with liver disease
• Caution in patients with bleeding disorders
• Monitor blood sugar levels in diabetics

Pregnancy

Use during pregnancy is not recommended due to potential effects on the fetus.

Breast-feeding

Limited data available; use with caution as clove can affect milk production.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Dried whole cloves
• Powdered clove

Indications

• Mild to moderate muscle pain
• Joint pain
• Backache
• Arthritis-related discomfort
• Sports injuries
• Strains and sprains

Dosage

Children: For children, refer to specific guidelines based on age and weight, and consult a healthcare professional for appropriate dosing.

Adults: Apply a thin layer to the affected area up to three times daily, or as directed by a healthcare professional.

Mechanism of action

The mechanism of action of dementholised is not fully elucidated, but it is believed to work by stimulating sensory neurons, which can lead to a reduction in the perception of pain. The modified formulation ensures that users receive the analgesic benefits while minimizing the cooling sensation typical of menthol.

Pharmacodynamics

Dementholised exhibits local analgesic properties by interacting with sensory neurons in the affected area. This interaction can promote blood flow and provide a sensation that helps to alleviate discomfort. The absence of menthol's cooling effect allows for a more neutral application, which may be preferable for certain patients.

Pharmacokinetics

Due to its topical application, dementholised is generally not absorbed significantly into systemic circulation. Its effects are localized to the site of application, which minimizes systemic side effects. The onset of action is typically rapid, with effects lasting for a few hours depending on the concentration and area of application.

Pregnancy

There is limited data on the safety of dementholised during pregnancy. Caution is advised, and it should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Dementholised should be used with caution during breastfeeding, as it is not known whether it is excreted in human milk.

Storage

Store at room temperature, in a tightly closed container, away from moisture and heat.

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Indications

• Digestive issues
• Nausea
• Headaches
• Respiratory conditions
• Oral hygiene
• Muscle pain relief

Dosage

Children: Dosage should be determined based on age and formulation. Consult specific product instructions and healthcare providers.

Adults: Dosage varies based on preparation and indication. For herbal formulations, refer to specific product guidelines.

Mechanism of action

The active compounds in mint, particularly menthol and menthone, exert their effects primarily through activation of the TRPM8 receptor, which is a cold and menthol receptor. This activation induces a cooling sensation and may provide analgesic effects. Menthol also acts as a smooth muscle relaxant, which can help alleviate gastrointestinal discomfort.

Pharmacodynamics

Mint exhibits various pharmacological effects, including carminative, antispasmodic, and mild analgesic properties. It is known to enhance gastric motility and reduce symptoms of irritable bowel syndrome (IBS). The menthol component may also exhibit mild anti-inflammatory properties and has been used in topical formulations for its cooling and soothing effects.

Pharmacokinetics

After ingestion, mint compounds are rapidly absorbed in the gastrointestinal tract. Menthol is metabolized primarily in the liver, undergoing conjugation. The elimination half-life of menthol is roughly 1-3 hours. The compounds are excreted mainly through urine, with a small percentage being exhaled as volatile constituents.

Adverse effects

• Allergic reactions
• Gastrointestinal disturbances
• Heartburn
• Headaches

Interactions

• May interact with medications that affect the liver enzymes responsible for its metabolism
• Potential interaction with antacids

Precautions

• Use with caution in individuals with gastroesophageal reflux disease (GERD)
• May cause allergic reactions in sensitive individuals

Pregnancy

Generally considered safe when used in food amounts. High doses should be avoided due to potential effects on uterine tone.

Breast-feeding

Generally safe in usual dietary amounts. Consult healthcare provider for concentrated supplements.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Fresh leaves
• Dried leaves
• Essential oil
• Teas

Dosage

Children: Refer to the BNF for Children or specific drug guidelines for appropriate paediatric dosing.

Adults: Refer to the specific drug formulation for appropriate dosing guidelines, as racemic mixtures encompass a wide range of drugs with varying indications and dosing regimens.

Mechanism of action

The mechanism of action of racemic mixtures depends on the specific drug in question. Generally, enantiomers can interact differently with biological targets such as receptors, enzymes, and transporters, leading to varied pharmacological effects. One enantiomer may have a stronger affinity for a receptor or may activate a different signaling pathway than the other.

Pharmacodynamics

Pharmacodynamics of racemic drugs can be complex, given that the two enantiomers may exert different actions. Typically, one enantiomer may be responsible for the desired therapeutic effect, while the other may contribute to side effects or have no effect at all. The overall effect of a racemic mixture will depend on the relative potency and efficacy of each enantiomer.

Pharmacokinetics

The pharmacokinetics of racemic mixtures can vary based on the enantiomers' absorption, distribution, metabolism, and excretion (ADME) properties. Differences in these properties can lead to discrepancies in plasma concentration levels and half-lives of the enantiomers. It is essential to evaluate the pharmacokinetics of each enantiomer individually, as one may be metabolized more quickly or have a different volume of distribution than the other.

Pregnancy

Data on the safety of racemic mixtures during pregnancy is limited. Caution is advised, and usage should only be considered if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if racemic mixtures are excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct light and moisture. Ensure that the medication is kept out of reach of children.

Mechanism of action

Camphor is a naturally occurring compound that is used as a major active ingredient of balms and liniments supplied as topical analgesics. ... Capsaicin and menthol, two other topically applied agents widely used for similar purposes, are known to excite and desensitize sensory nerves by acting on two members of transient receptor potential (TRP) channel superfamily: heat-sensitive TRP vanilloid subtype 1 (TRPV1) and cold-sensitive TRP channel M8, respectively. Camphor has recently been shown to activate TRPV3, and here /investigators/ show that camphor also activates heterologously expressed TRPV1, requiring higher concentrations than capsaicin. Activation was enhanced by phospholipase C-coupled receptor stimulation mimicking inflamed conditions. Similar camphor-activated TRPV1-like currents were observed in isolated rat DRG neurons and were strongly potentiated after activation of protein kinase C with phorbol-12-myristate-13-acetate. Camphor activation of rat TRPV1 was mediated by distinct channel regions from capsaicin, as indicated by camphor activation in the presence of the competitive inhibitor capsazepine and in a capsaicin-insensitive point mutant. Camphor did not activate the capsaicin-insensitive chicken TRPV1. TRPV1 desensitization is believed to contribute to the analgesic actions of capsaicin. /The authors/ found that, although camphor activates TRPV1 less effectively, camphor application desensitized TRPV1 more rapidly and completely than capsaicin. Conversely, TRPV3 current sensitized after repeated camphor applications, which is inconsistent with the analgesic role of camphor. /Investigators/ also found that camphor inhibited several other related TRP channels, including ankyrin-repeat TRP 1 (TRPA1). The camphor-induced desensitization of TRPV1 and block of TRPA1 may underlie the analgesic effects of camphor.

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/